| NDC Code | 53877-001-13 |
|---|
| Package Description | 30 BAG in 1 CASE (53877-001-13) > 70 mL in 1 BAG |
|---|
| Product NDC | 53877-001 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Teruflex Blood Bag System Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) |
|---|
| Non-Proprietary Name | Anticoagulant Citrate Phosphate Dextrose Adenine (cpda-1) |
|---|
| Dosage Form | SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20120522 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | BN820528 |
|---|
| Manufacturer | Terumo Corporation |
|---|
| Substance Name | ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE |
|---|
| Strength | .275; 2.99; 31.9; 2.22; 26.3 |
|---|
| Strength Unit | g/1000mL; g/1000mL; g/1000mL; g/1000mL; g/1000mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Acidifying Activity [MoA], Anti-coagulant [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE], Decreased Coagulation Factor Activity [PE] |
|---|